Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziwei Fang

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
American Journal of Cancer Research|December 7, 2021
Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancerAllison Staley, Katherine Tucker, Yajie Yin, et al.
Frontiers in Pharmacology|December 19, 2024
<i>Asparagus officinalis</i> L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancerZiwei Fang, Weimin Kong, Ziyi Zhao, et al.
Mechanisms of Ageing and Development|April 13, 2025
miR-34a-5p/MARCHF8/ADAM10 axis in the regulation of vascular endothelial cell dysfunction and senescenceZonghao Qian, Yuzhen Huang, Ni Yang, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancerZiyi Zhao, Jiandong Wang, Weimin Kong, et al.
Gynecologic Oncology|April 26, 2024
Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancerZiyi Zhao, Jiandong Wang, Weimin Kong, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 9, 2021
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancerStuart R Pierce, Ziwei Fang, Yajie Yin, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
American Journal of Cancer Research|December 7, 2021
Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancerAllison Staley, Katherine Tucker, Yajie Yin, et al.
Frontiers in Pharmacology|December 19, 2024
<i>Asparagus officinalis</i> L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancerZiwei Fang, Weimin Kong, Ziyi Zhao, et al.
Mechanisms of Ageing and Development|April 13, 2025
miR-34a-5p/MARCHF8/ADAM10 axis in the regulation of vascular endothelial cell dysfunction and senescenceZonghao Qian, Yuzhen Huang, Ni Yang, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancerZiyi Zhao, Jiandong Wang, Weimin Kong, et al.
Gynecologic Oncology|April 26, 2024
Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancerZiyi Zhao, Jiandong Wang, Weimin Kong, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 9, 2021
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancerStuart R Pierce, Ziwei Fang, Yajie Yin, et al.
Pageof 4